Teladoc Health Inc

Teladoc Health Inc(TDOC)股票分析

$6.450

+0.217 (+3.37%)收盘时

Loading chart…
最高
6.460
开盘
6.250
成交量加权均价
6.36
成交量
3.98M
市值
1.72B
最低
6.180
成交额
25.31M
企业价值/息税折旧摊销前利润(TTM)
5.88

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

AI 分析 of Teladoc Health Inc (TDOC)

持有

Teladoc Health Inc is not a strong buy right now. The current price is $6.34, which is below the analyst price targets of $7.50 and $8.00, indicating limited upside potential. Additionally, the RSI is at 70.49, suggesting the stock is overbought, which could lead to a price correction. The main risk is the forward P/E ratio of 303.03, indicating that the stock is highly valued compared to its earnings, which may deter long-term investors.

分析师评级(13)

上行空间 +38.14%
买入
10 买入
3 持有
0 卖出
当前: 6.45
最低
7.50
平均
8.91
最高
12.00

Citi

2026-08-03

目标价

$11

持有

Jefferies

2026-07-30

目标价

$8

持有

Evercore ISI

2026-07-30

目标价

$10

持有

Citi

2026-07-23

目标价

$11

中性

Canaccord

2026-07-21

目标价

$11

买入

估值指标

Teladoc Health Inc(TDOC)当前预期市盈率为 303.03,5 年平均预期市盈率为 34.93。

预期市盈率

严重高估
5 年均值 P/E
34.93
当前P/E
303.03
高估
156.54
低估
-86.68

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.69
当前EV/EBITDA
5.88
高估
28.43
低估
0.94

预期市销率

合理
5 年均值 P/S
1.47
当前P/S
0.47
高估
3.07
低估
-0.12

Alphio AI 对 TDOC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%TDOC

$7.29

情景价格

基

基准

基准 · 50%TDOC

$6.49

情景价格

悲

悲观

悲观 · 25%TDOC

$6.11

情景价格

持有 TDOC 的大户

V

Voss Capital, LP

+ 持有TDOC

-0.55%

3个月收益率

P

Pale Fire Capital SE

+ 持有TDOC

-1.96%

3个月收益率

事件时间线

2026-09-25 (ET)

09:00:00

Teladoc Health Announces Legal Executive Transition

2026-08-31 (ET)

08:30:00

Teladoc Appoints Michael Grasher as CFO

2026-08-26 (ET)

10:30:00

Canada Raises Tariffs on U.S. Steel and Aluminum to 50%

2026-07-30 (ET)

17:00:00

Microsoft's Strong Earnings Boost Market Recovery

资讯

TDOC 常见问题 —— 由 Alphio AI 解答

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Teladoc Health Inc is not a strong buy right now. The current price is $6.34, which is below the analyst price targets of $7.50 and $8.00, indicating limited upside potential. Additionally, the RSI is at 70.49, suggesting the stock is overbought, which could lead to a price correction. The main risk is the forward P/E ratio of 303.03, indicating that the stock is highly valued compared to its earnings, which may deter long-term investors.

13 analysts cover TDOC: 10 rate it Buy, 3 Hold and 0 Sell. The average price target is 8.91.

FlashMonk5天前

$TDOC Watching this to see if it can start to trend over the 200 (blue line) and into that gap. My alert is 6.75 to take another look. Have a great weekend.

展开
注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易